DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF LEFT VENTRICULAR CLOT, A CASE SERIES AND LITERATURE REVIEW
Raed Aqel*, MD and Mohammed Alqadi MD
Five patients with the diagnosis of left ventricular (LV) clot, resulting from ischemic and non ischemic cardiomyopathy, were identified between February 2015 and February 2019, as they were deemed vitamin K antagonist’s inappropriate because of the poor compliance with checking the level of anticoagulation. These patients were placed on direct oral anticoagulants (DOACs), and were followed clinically and by echocardiography for six months up to four years period. During such period, there has not been any identification of thrombo-embolic events to any of these patients, whereas echocardiography was performed at 1 and 3-6 months post initiation of DOACs.
[Full Text Article]